The pathophysiology of noise-induced hearing loss (NIHL) encompasses excessive inflammation, tissue damage, production of reactive oxygen species, and apoptotic processes, culminating in irreversible damage to hair cells. Currently, no clinical interventions are available to mitigate this condition....
✦ Clinical Takeaway ✦
No actionable change for clinical practice — findings are limited to a mouse model of noise-induced hearing loss and require human trials before any clinical application can be considered.
✦ Why It Matters ✦
Identifying Alpha1-Antitrypsin as a protective agent against noise-induced hearing loss adds to the growing body of evidence that anti-inflammatory and anti-oxidative strategies may be viable targets for otoprotective therapies.
✦ Key Points ✦
- 01Human Alpha1-Antitrypsin (A1AT) reduced noise-induced hearing loss in a mouse model.
- 02